T&R Biofab Co., Ltd.

Equities

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
7,850 ^KRW	-1.63%		-1.51%	-12.09%

2023	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
2023	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI

T&R Biofab Co., Ltd. has completed an IPO in the amount of KRW 21.6 billion.

November 21, 2018 at 12:00 am EST

T&R Biofab Co., Ltd. has completed an IPO in the amount of KRW 21.6 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,200,000 PriceRange: KRW 18000 Discount Per Security: KRW 810 Transaction Features: Sponsor Backed Offering

Latest news about T&R Biofab Co., Ltd.

T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	Dec. 21	CI
T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	Dec. 13	CI
CJ Foods Partners with T&R Biofab to Shape the Future of Food	23-10-18	CI
T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	23-08-03	CI
T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	23-07-25	CI
T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	21-09-20	CI
T&R Biofab Co., Ltd. announced that it has received KRW 35 billion in funding from a group of investors	21-08-05	CI
T&R Biofab Co., Ltd. announced that it expects to receive KRW 35 billion in funding from a group of investors	21-07-05	CI
T&R Biofab Co., Ltd. announced that it has received KRW 13.99997475 billion in funding from Korea Investment Partners Co. Ltd., eBest Investment Securities Co., Ltd., Investment Arm	20-10-07	CI
T&R Biofab Co., Ltd. announced that it expects to receive KRW 13.99997475 billion in funding from Korea Investment Partners Co. Ltd., eBest Investment Securities Co., Ltd., Investment Arm and other investors	20-09-28	CI
T&R Biofab Co., Ltd. has completed an IPO in the amount of KRW 21.6 billion.	18-11-21	CI
T&R Biofab Co., Ltd. has filed an IPO.	18-07-30	CI
T&R Biofab Co., Ltd. has withdrawn its IPO.	18-07-29	CI
T&R Biofab Co., Ltd. has filed an IPO.	16-09-08	CI

Chart T&R Biofab Co., Ltd.

Duration

Period

More charts

Company Profile

T&R Biofab Co., Ltd. is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Devices & Implants

	1st Jan change	Capi.
T&R BIOFAB CO., LTD.	-12.09%	125M
STRYKER CORPORATION	+8.67%	125B
SMITH & NEPHEW PLC	-10.82%	10.51B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-5.04%	8.65B
GLAUKOS CORPORATION	+21.40%	4.77B
AXONICS, INC.	+7.58%	3.42B
ENOVIS CORPORATION	-0.34%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-13.27%	1.97B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-12.45%	1.95B
DOUBLE MEDICAL TECHNOLOGY INC.	-30.28%	1.62B

Medical Devices & Implants